JARDIANCE (empagliflozin) is now listed on the PBS for Australian patients with chronic kidney disease (CKD) with or without diabetes.
The listing comes off the back of the recent new indication granted by the TGA (PD 23 Feb).
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Apr 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Apr 24
